Faculty profile

Caroline Lamarche

ResearcherNephrologyUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Caroline Lamarche

Researcher

Nephrology

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
18 publications in the last five years, latest in 2026.
Senior (last) author on 7 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Chronic Kidney Disease Immunotherapy Regulatory T Cells Tregs Uremic Cardiomyopathy Uremic Toxins

Latest papers

Engineering human Tregs to resist tacrolimus via FKBP12 gene editing.
Frontiers in immunology · 2026 · senior author
SMOC2 promotes partial epithelial-mesenchymal transition and maladaptive repair in renal tubular epithelial cells.
JCI insight · 2026
Diagnostic Potential of Urine CXCL10 and Donor-Derived cfDNA in Kidney Transplant Rejection.
Transplant international : official journal of the European Society for Organ Transplantation · 2026

All 33 publications

Latest funding

Cardiovascular and Renal Protection with SGLT Inhibition in Kidney Transplant Recipients" ('RENAISSANCE') Study
CIHR · 2026 · Co-investigator
$2,300,300
To Immunity & Beyond: A National Webinar Series on Immunology, Infection, Organ Donation, and Transplantation Research
CIHR · 2025 · Co-investigator
$20,000
Regulatory T cells (Tregs): a new therapeutic target for uremic cardiomyopathy?
CIHR · 2025 · Nominated PI
$933,300

All 5 grants and awards

33 publications.

Engineering human Tregs to resist tacrolimus via FKBP12 gene editing.

Requejo Cier CJ, Valentini N, Boudreau G, Delisle JS, Lamarche C

Frontiers in immunology2026Senior author

DOI: 10.3389/fimmu.2026.1756624 PMID: 42079647

SMOC2 promotes partial epithelial-mesenchymal transition and maladaptive repair in renal tubular epithelial cells.

Cenatus S, Gao P, Henley N, Lamarche C, Liu XS, Mallette FA, Barrera-Chimal J, Gerarduzzi C

JCI insight2026

DOI: 10.1172/jci.insight.198555 PMID: 42585118

Diagnostic Potential of Urine CXCL10 and Donor-Derived cfDNA in Kidney Transplant Rejection.

Fantus D, Balshaw R, Saw CL, Belkaid M, Tangprasertchai NS, Viard T, Gougeon F, Belair J, Daniel C, Lamarche C, Casas S, Cardinal H, Ho J

Transplant international : official journal of the European Society for Organ Transplantation2026

DOI: 10.3389/ti.2026.15517 PMID: 41970280

Sucralose as a Way to Enhance Regulatory T Cells, the SWEET Trial: Clinical Research Protocol.

Bourguignon L, Benazzouk Y, Bokou-Gianneli E, Zani F, Blagih J, Lamarche C

Canadian journal of kidney health and disease2026Senior author

DOI: 10.1177/20543581261418540 PMID: 41694241

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Schweitzer L, Thiant S, Thérien C, Giroux M, Lachance S, Fleury I, Orio J, Carli C, Boudreau G, Patenaude J, Tremblay-Laganière C, Senécal L, Dufresne SF, Mollica L, Collette S, Sauvageau G, Kiss T, Cohen S, Bernard L, Bambace N, Veilleux O, Ahmad I, Roy J, Busque L, Duval M, Bittencourt H, Teira P, Lamarche C, Roy DC, Delisle JS

Open forum infectious diseases2026

DOI: 10.1093/ofid/ofag006 PMID: 41614086

Renal hemosiderosis secondary to intravascular hemolytic anemia.

Royal V, Lamarche C

Kidney international2025Senior author

DOI: 10.1016/j.kint.2025.05.033 PMID: 41110895

Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delayed graft function study: study protocol of the CINERGY Pilot randomised controlled trial

D'Aragon F, Selzner M, Breau R, Masse M-H, Lamontagne F, Masse M, Chassé M, Carrier F-M, Cardinal H, Chaudhury P

BMJ Open20243 citations

DOI: 10.1136/bmjopen-2024-086777

Assessment of renal perfusion with 82-rubidium PET in patients with normal and abnormal renal function.

Bibeau-Delisle A, Bouabdallaoui N, Lamarche C, Harel F, Pelletier-Galarneau M

Nuclear medicine communications2024

DOI: 10.1097/mnm.0000000000001890 PMID: 39155795

Identification of inflammatory biomarkers in IgA nephropathy using the NanoString technology: a validation study in Caucasians.

Gaumond L, Lamarche C, Beauchemin S, Henley N, Elftouh N, Gerarduzzi C, Laurin LP

Inflammation research : official journal of the European Histamine Research Society ... [et al.]2024

DOI: 10.1007/s00011-023-01848-3 PMID: 38291238

Unlocking the potential of Tregs: innovations in CAR technology.

Requejo Cier CJ, Valentini N, Lamarche C

Frontiers in molecular biosciences2023Senior author

DOI: 10.3389/fmolb.2023.1267762 PMID: 37900916

Cardiovascular and Renal Protection with SGLT Inhibition in Kidney Transplant Recipients" ('RENAISSANCE') Study

Co-investigatorCIHR2026Project Grant

Principal investigators: Srinivasan Sridhar, Vikas; Cherney, David Z; Gill, John S; Matas, Arthur J; Mottl, Amy K; Sawinski, Deirdre; Singh, Sunita K

Keywords: Cardiovascular Disease; Chronic Kidney Disease; Heart Failure; Kidney Transplantation; Sglt Inhibition

$2,300,300

To Immunity & Beyond: A National Webinar Series on Immunology, Infection, Organ Donation, and Transplantation Research

Co-investigatorCIHR2025Planning and Dissemination Grant - Institute Community Support

Principal investigators: Migneault, Francis

Keywords: Immunity; Infection; Knowledge Dissemination; Transplantation

$20,000

Regulatory T cells (Tregs): a new therapeutic target for uremic cardiomyopathy?

Nominated PICIHR2025Project Grant

Principal investigators: Lamarche, Caroline

Keywords: Chronic Kidney Disease; Immunotherapy; Regulatory T Cells; Tregs; Uremic Cardiomyopathy; Uremic Toxins

$933,300

The Molecules and Mechanisms Mediating Kidney Health and Disease (M3K) Meeting and Investigator Summit

Co-investigatorCIHR2022Planning and Dissemination Grant - Institute Community Support

Principal investigators: Torban, Elena

Keywords: Biomarkers; Canadian; Disease Models; Diversity; Genetics; Kidney; Kidney Injury; Knowledge Translation; Mechanisms Of Disease; Molecular Biology

$10,000

Impact of COVID-19 on Patients Receiving Hemodialysis: The Quebec Renal Network (QRN) COVID-19 Study

Co-investigatorCIHR2020Op Gr: COVID-19 Rapid Research FO - Clinical Mgmt/Health System Interventions

Principal investigators: Suri, Rita; Beaubien-Souligny, William; Nadeau-Fredette, Annie-Claire

Keywords: Covid-19; Health Outcomes; Hemodialysis; Hospitalisation; Infection Prevention And Control; Mortality; Observational Study; Pandemic; Patient-Reported Outcome Measures; Qualitative Study

$476,333

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Caroline Lamarche

Research

Latest papers

Latest funding

Engineering human Tregs to resist tacrolimus via FKBP12 gene editing.

SMOC2 promotes partial epithelial-mesenchymal transition and maladaptive repair in renal tubular epithelial cells.

Diagnostic Potential of Urine CXCL10 and Donor-Derived cfDNA in Kidney Transplant Rejection.

Sucralose as a Way to Enhance Regulatory T Cells, the SWEET Trial: Clinical Research Protocol.

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Renal hemosiderosis secondary to intravascular hemolytic anemia.

Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delayed graft function study: study protocol of the CINERGY Pilot randomised controlled trial

Assessment of renal perfusion with 82-rubidium PET in patients with normal and abnormal renal function.

Identification of inflammatory biomarkers in IgA nephropathy using the NanoString technology: a validation study in Caucasians.

Unlocking the potential of Tregs: innovations in CAR technology.

Cardiovascular and Renal Protection with SGLT Inhibition in Kidney Transplant Recipients" ('RENAISSANCE') Study

To Immunity & Beyond: A National Webinar Series on Immunology, Infection, Organ Donation, and Transplantation Research

Regulatory T cells (Tregs): a new therapeutic target for uremic cardiomyopathy?

The Molecules and Mechanisms Mediating Kidney Health and Disease (M3K) Meeting and Investigator Summit

Impact of COVID-19 on Patients Receiving Hemodialysis: The Quebec Renal Network (QRN) COVID-19 Study

Frequent collaborators

Annie-Claire Nadeau-Fredette

Annie-Claire Nadeau-Fredette

Casimiro Gerarduzzi

William Beaubien-Souligny

William Beaubien-Souligny

Lambert Busque

Darin Treleaven

Steven Hanna

Karen Burns

Tomoko Takano

Julie Ho

Francois Lamontagne

Alexandre Prat

Andras Kapus

Elena Torban

Sunny Hartwig

François Lauzier

Jean Roy

Dylan Burger

Katalin Szaszi